Skip to content
Screener

Lucid Diagnostics LUCD Q2 2025 earnings

Reported August 13, 2025 · Before market open

Revenue$1.2MMiss by $549.3K
EPS-$0.10Miss by $0.01
Revenue estimate$1.7M
EPS estimate-$0.09

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$1.7M
EPS estimate-$0.04

Financials

Q2 2025

Income statement

See full
Revenue$1.2M+19.2%
Gross profit-$400.0K+41.9%
Operating income-$11.4M-1.7%
Net income-$4.4M+59.7%
EPS (diluted)-$0.08+65.2%

Balance sheet

See full
Cash & equivalents$31.1M+24.9%
Total debt$2.3M-25.8%
Total equity$7.9M-50.8%
Total assets$38.7M+13.4%

Cash flow

See full
Operating cash flow-$10.5M+8.1%
CapEx$25.0K-66.2%
Free cash flow-$10.6M+4.8%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$128.75M+249%
Enterprise value$99.9M+564%
P/S29.5×+19.8×

Profitability

See full
Gross margin-57.3%—
Operating margin-1,099.5%-64.6pp
Net margin-1,267.4%+42.3pp
FCF margin-1,040.1%—

Returns & leverage

See full
Return on equity-463.6%+550pp
Debt / equity0.3×+0.1×
Current ratio1.1×-0.6×

FAQ

When did Lucid Diagnostics report Q2 2025 earnings?
Lucid Diagnostics (LUCD) reported Q2 2025 earnings on August 13, 2025 before market open.
What were Lucid Diagnostics's Q2 2025 revenue and EPS?
Lucid Diagnostics reported revenue of $1.2M and eps of $-0.10 for Q2 2025.
Did Lucid Diagnostics beat estimates in Q2 2025?
Revenue missed the consensus estimate of $1.7M by $549.3K. EPS missed the consensus estimate of $-0.09 by $0.01.
How did Lucid Diagnostics's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 19.2% from $976.0K a year earlier and eps grew 50.0% from $-0.20.
Where can I find Lucid Diagnostics's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-011882) and the 10-Q periodic report (0001493152-25-011862) directly on SEC EDGAR. The filing index links above go to sec.gov.